Extended protection can be provided to patients when inhalation devices are used in combination. Consider the example from the US of GlaxoSmithKline’s Advair (seretide) formulation, which came ...

In February 2010, aztreonam for inhalation solution (Cayston; Gilead) — an inhalable formulation of the monobactam antibiotic aztreonam and lysine — was approved by the US FDA to improve ...

Delivery of growth hormone to children by inhalation is a viable alternative ... one possibility is an inhaled formulation of growth hormone. Inhaled growth hormone has already undergone ...

"The acquisition of Vectura reflects our commitment to advancing industry-leading medical capabilities for our customers," said Joe Nelligan, CEO, Molex, which acquired Phillips Medisize in 2016.

YUTREPIA is a dry-powder formulation of treprostinil ... shape and composition for optimal lung deposition after oral ...

Expands Phillips Medisize’s inhalation drug delivery capabilities.

Molex has entered an agreement to acquire UK-based inhalation drug device design and formulation company Vectura Group, via ...

Phillips Medisize parent company Molex has completed its acquisition of Vectura from a subsidiary of cigarette maker Philip ...